Kanisa Pharmaceuticals Overview
- Year Founded
-
2004
- Status
-
Private
- Latest Deal Type
-
Liquidation
Kanisa Pharmaceuticals General Information
Description
Provider of oncology focused pharmaceutical services. The company is focused on developing new treatments for cancer with novel testing formats to stratify patients and predict likely responders to therapy.
Contact Information
Website
www.kanisapharm.comCorporate Office
- 12264 El Camino Real
- Suite 300
- San Diego, CA 92130
- United States
Corporate Office
- 12264 El Camino Real
- Suite 300
- San Diego, CA 92130
- United States
Kanisa Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Bankruptcy: Liquidation | 01-Jan-2018 | Completed | Out of Business | |||
| 1. Early Stage VC (Series A) | 27-Dec-2004 | Completed | Startup |
Kanisa Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Kanisa Pharmaceuticals Patents
Kanisa Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2006269498-A1 | Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins | Inactive | 06-Jul-2005 | ||
| CA-2630087-A1 | Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins | Inactive | 06-Jul-2005 | ||
| EP-1898957-A1 | Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins | Inactive | 06-Jul-2005 | ||
| US-20070010485-A1 | Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins | Inactive | 06-Jul-2005 | ||
| US-20070010486-A1 | Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins | Inactive | 06-Jul-2005 | A61K47/40 |
Kanisa Pharmaceuticals FAQs
-
When was Kanisa Pharmaceuticals founded?
Kanisa Pharmaceuticals was founded in 2004.
-
Where is Kanisa Pharmaceuticals headquartered?
Kanisa Pharmaceuticals is headquartered in San Diego, CA.
-
What industry is Kanisa Pharmaceuticals in?
Kanisa Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Kanisa Pharmaceuticals a private or public company?
Kanisa Pharmaceuticals is a Private company.
-
What is Kanisa Pharmaceuticals’s current revenue?
The current revenue for Kanisa Pharmaceuticals is .
-
How much funding has Kanisa Pharmaceuticals raised over time?
Kanisa Pharmaceuticals has raised $24.8M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process